NCT06512701

Brief Summary

Excessive or insufficient levels of vitamins in the body can affect health. With the prevalence of obesity and MetS, NAFLD has become the leading cause of chronic liver disease and abnormal liver biochemical indicators in health examinations in China. The current research results on serum vitamin A, D, and E levels in NAFLD patients are controversial. Therefore, this study mainly explores the correlation between serum FSV levels and NAFLD, providing reference for nutrition and clinical management of NAFLD patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Jul 2024Jul 2026

Study Start

First participant enrolled

July 3, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2026

Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

July 10, 2024

Last Update Submit

July 17, 2024

Conditions

Keywords

cross-sectional studycorrelationdose-response relationship

Outcome Measures

Primary Outcomes (5)

  • non-alcoholic fatty liver disease prevanlence

    Day 1

  • serum vitamin A

    Day 1

  • serum vitamin D

    Day 1

  • serum vitamin E

    Day 1

  • serum vitamin k

    Day 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 and above who underwent physical examinations at the Health Management Center of the First Affiliated Hospital of Zhejiang University School of Medicine from July 2024 to June 2026.

You may qualify if:

  • Age ≥ 18 years old, both male and female;
  • Voluntarily participate in this study and sign an informed consent form;
  • Diagnosed NAFLD through abdominal ultrasound;

You may not qualify if:

  • Acute and chronic infections, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, urinary system diseases, rheumatic diseases, tumors, and pituitary dysfunction; Or have hepatitis B, hepatitis C virus, or acquired immunodeficiency syndrome;
  • Surgery was performed within 6 months, and blood donation, transfusion, or significant blood loss occurred within 4 months;
  • Have taken vitamin supplements within 2 weeks;
  • Women are in pregnancy, lactation, or within one year after childbirth;
  • Alcohol abuse (alcohol intake ≥ 140 g/week for males and ≥ 70 g/week for females)
  • The serum creatinine (SCr) exceeds twice the following abnormal values, with the standard of abnormal values being: male (20-59 years old)\>97 μ mol/L, male (60-79 years old)\>111 μ mol/L; Female (20-59 years old)\>73 μ mol/L, female (60-79 years old)\>81 μ mol/L.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, 310003, China

RECRUITING

MeSH Terms

Conditions

Non-alcoholic Fatty Liver DiseaseDisease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Zhong Liu, MD

    First Affiliated Hospital of Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 10, 2024

First Posted

July 22, 2024

Study Start

July 3, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 10, 2026

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations